Changes in Hong Kong stocks | Liangqing Holdings (03774) surged more than 28%, and the company launched a new “medical aesthetic+AI” narrative, rapid business expansion in the past three years

The Zhitong Finance App learned that Liangqing Holdings (03774) surged more than 28% intraday. On June 30 this year, Liangqing Holdings successfully transferred from GEM to the main board listing, and officially entered the Hong Kong Stock Connect list in just over two months. As of press release, it rose 23.31% to HK$36.50, with a turnover of HK$52,078 million.

According to public information, as a medical aesthetic service provider, Liangqing Holdings operates “per Face” brand medical aesthetic centers in superior locations such as Causeway Bay, Tsimshatsui, Mongkok and Central in Hong Kong, as well as in Macau. It is worth mentioning that the company is anchoring its strategic focus on the “AI+ High-End Biotech Skincare” circuit. In July of this year, Liangqing Holdings' “AI Anti-Aging” platform development was launched, and Hong Kong AI company Sunseeker was commissioned to develop a model.

The company's operations have expanded rapidly over the past three years. For the years ended 2024, 2025 and March 31, 2026, the company's revenue was approximately HK$299 million, HK$435 million and HK$590 million respectively, with a compound annual growth rate of over 40%; net profit also increased steadily from approximately HK$41 million to HK$55 million. At the same time, the customer base expanded significantly, and the number of active customers nearly doubled from about 13,000 in FY2024 to about 24,000 in FY2026.